We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAACW
1276
CALL
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
$2.92M 0.01%
298,956
AGGRW
1277
CALL
DELISTED
Agile Growth Corp Warrant
AGGRW
$2.92M 0.01%
299,997
AONCW
1278
CALL
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$2.91M 0.01%
300,222
MTOR
1279
DELISTED
MERITOR, Inc.
MTOR
$2.91M 0.01%
+136,646
New +$3.18M
FVRR icon
1280
Fiverr
FVRR
$398M
$2.91M 0.01%
15,930
+3,799
+31% +$765K
GIWWW
1281
CALL
DELISTED
GigInternational1, Inc. Warrant
GIWWW
$2.91M 0.01%
+294,497
New +$250K
SST icon
1282
System1
SST
$15.7M
$2.9M 0.01%
29,292
-1,352
-4% -$134K
SOC.WS
1283
CALL
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$2.9M 0.01%
298,695
FLNG icon
1284
FLEX LNG
FLNG
$1.65B
$2.9M 0.01%
162,064
-33,087
-17% -$495K
LCID icon
1285
Lucid Motors
LCID
$2.54B
$2.9M 0.01%
11,415
+383
+3% +$88.7K
CGNT icon
1286
Cognyte Software
CGNT
$642M
$2.9M 0.01%
+140,949
New +$3.6M
SPWRW
1287
CALL
SunPower Inc Warrants
SPWRW
$2.23M
$2.9M 0.01%
297,432
JWSM.WS
1288
CALL
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$2.9M 0.01%
296,754
CF icon
1289
CF Industries
CF
$18.4B
$2.89M 0.01%
+51,828
New +$2.49M
GDEVW icon
1290
CALL
GDEV Inc Warrant
GDEVW
$60.8K
$2.89M 0.01%
+435,299
New +$366K
AZEK
1291
DELISTED
The AZEK Co
AZEK
$2.89M 0.01%
+79,076
New +$3.08M
WALDW icon
1292
CALL
Waldencast PLC Warrant
WALDW
$4.53M
$2.89M 0.01%
294,448
PL icon
1293
Planet Labs
PL
$7.48B
$2.88M 0.01%
290,846
+37,471
+15% +$371K
GCMGW
1294
CALL
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
$2.88M 0.01%
250,000
+50,000
+25% +$85.1K
ECHO
1295
EchoStar
ECHO
$25.1B
$2.86M 0.01%
112,049
-178,135
-61% -$4.39M
BKU icon
1296
Bankunited
BKU
$3.36B
$2.85M 0.01%
+68,074
New +$2.79M
CCL icon
1297
PUT
Carnival Corporation Ltd
CCL
$37.1B
$2.84M 0.01%
113,600
+28,100
+33% +$654K
METC icon
1298
Ramaco Resources Class A
METC
$664M
$2.83M 0.01%
237,401
+204,989
+632% +$1.71M
GAPA
1299
DELISTED
G&P Acquisition Corp.
GAPA
$2.81M 0.01%
+285,109
New +$2.78M
TRIL
1300
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.81M 0.01%
160,062
-256,862
-62% -$3M

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.